HomeIDXG • OTCMKTS
Follow
Interpace Biosciences Inc
Previous close
$1.60
Day range
$1.56 - $1.56
Year range
$0.62 - $3.54
Market cap
6.72M USD
Avg Volume
6.81K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 10.28M | 23.42% |
Operating expense | 4.82M | -1.07% |
Net income | 889.00K | 156.84% |
Net profit margin | 8.65 | 146.08% |
Earnings per share | — | — |
EBITDA | 1.39M | 180.44% |
Effective tax rate | 0.73% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.50M | -27.55% |
Total assets | 13.02M | -18.51% |
Total liabilities | 74.69M | 129.72% |
Total equity | -61.67M | — |
Shares outstanding | 4.33M | — |
Price to book | -0.11 | — |
Return on assets | 24.18% | — |
Return on capital | -10.26% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 889.00K | 156.84% |
Cash from operations | 1.14M | 513.04% |
Cash from investing | -142.00K | 87.08% |
Cash from financing | -2.53M | -2,288.68% |
Net change in cash | -1.53M | -3.58% |
Free cash flow | 10.56M | 1,051.08% |
About
Founded
1986
Headquarters
Website
Employees
94